Interaction of molecules of the neonicotinoid imidacloprid and its structural analogs with human serum albumin

  • K. I. Mikhailopulo
  • T. S. Serchenya
  • E. P. Kiseleva
  • Yu. G. Chernov
  • T. M. Tsvetkova
  • N. V. Kovganko
  • O. V. Sviridov

We have used fluorescence spectroscopy methods to show that imidacloprid and its structural analogs form complexes with human serum albumin (HSA). The nature of the spectral changes in the ligand×protein systems and the calculated complexation parameters suggest that these low molecular weight compounds mainly bind to a specific section of the protein molecule, near the tryptophan residue in the 214 position of the polypeptide chain. We have found that the association constants are on the order of 104 M−1, and the affinity of the ligands for HSA varies in the series 6-chloronicotinic acid > 6-methoxynicotinic acid = imidacloprid > the keto analog of imidacloprid. The major contribution to the complexation energy probably comes from hydrophobic interaction forces with participation of the aromatic pyridine ring of the ligands, while additional enhancement of ligand-protein affinity can be provided by the nitroimine group of imidacloprid.

Key words

human serum albumin neonicotinoid imidacloprid quenching of fluorescence ligand-protein binding 


  1. 1.
    K. Matsuda, S. D. Buckingham, D. Kleier, J. J. Rauh, M. Grauso, and D. B. Sattelle, Trends Pharmacol. Sci., 22, 573–580 (2001).CrossRefGoogle Scholar
  2. 2.
    M. Tomizawa and J. E. Casida, Ann. Rev. Pharmacol. Toxicol., 45, 247–268 (2005).CrossRefGoogle Scholar
  3. 3.
    I. Yamamoto, M. Tomizawa, T. Saito, T. Miyamoto, E. C. Walcott, and K. Sumikawa, Arch. Insect. Biochem. Physiol., 37, 24–32 (1998).CrossRefGoogle Scholar
  4. 4.
    K. Matsuda, M. Shimomura, M. Ihara, M. Akamatsu, and D. B. Sattelle, Biosci. Biotechnol. Biochem., 69, 1442–1452 (2005).CrossRefGoogle Scholar
  5. 5.
    M. Tomizawa, T. T. Talley, D. Maltby, K. A. Durkin, K. F. Medzihradszky, A. L. Burlingame, P. Taylor, and J. E. Casida, Proc. Natl. Acad. Sci. USA, 104, 9075–9080 (2007).CrossRefADSGoogle Scholar
  6. 6.
    Y. Wang, J. Cheng, X. Qian, and Z. Li, Bioorg. Med. Chem., 15, 2624–2630 (2007).CrossRefGoogle Scholar
  7. 7.
    F. A. De Wolf and G. M. Brett, Pharmacol. Rev., 52, 207–236 (2000).Google Scholar
  8. 8.
    C. M. Mendel, Endocrinol. Rev., 10, 232–274 (1989).CrossRefGoogle Scholar
  9. 9.
    V. D. Luk'yanchuk and A. I. Luik, Zh. Klin. i Éksp. Meditsiny, 23, 33–37 (1983).Google Scholar
  10. 10.
    T. Cserhati and E. Forgacs, J. Chromatogr. A, 699, 285–290 (1995).CrossRefGoogle Scholar
  11. 11.
    M. Gulden, S. Tahan, and H. Seibert, Toxicology, 175, 201–213 (2002).CrossRefGoogle Scholar
  12. 12.
    D. Silva, C. M. Cortez, J. Cunha-Bastos, and S. R. Louro, Toxicol. Lett., 147, 53–61 (2004).CrossRefGoogle Scholar
  13. 13.
    E. S. Peeples, L. M. Schopfer, E. G. Duysen, R. Spaulding, T. Voelker, C. M. Thompson, and O. Lockridge, Toxicol. Sci., 83, 303–312 (2005).CrossRefGoogle Scholar
  14. 14.
    I. Mukherjee, Pest. Management Sci., 56, 932–936 (2000).CrossRefGoogle Scholar
  15. 15.
    N. V. Kovganko, Yu. G. Chernov, V. L. Survilo, and Zh. N. Kashkan, “Method for obtaining imidacloprid,” Belarus Patent No. 8491, IPC7 C07D401/06 (2004).Google Scholar
  16. 16.
    M.-X. Xie, X.-Y. Xu, and Y.-D. Wang, Biophys. Biochim. Acta, 1724, 215–224 (2005).Google Scholar
  17. 17.
    A. I. Luik and V. D. Luk'yanchuk, Serum Albumin and Biotransport of Toxins [in Russian], Meditsina, Moscow (1984), pp. 45–65.Google Scholar
  18. 18.
    J. R. Lakowicz, Principles of Fluorescence Spectroscopy [Russian translation from English; M. G. Kuz'min, ed.], Mir, Moscow (1986).Google Scholar
  19. 19.
    S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi, Protein Eng., 12, 439–446 (1999).CrossRefGoogle Scholar
  20. 20.
    G. Sudlow, D. J. Birkett, and D. N. Wade, Mol. Pharmacol., 11, 824–832 (1975).Google Scholar
  21. 21.
    Y. V. Il'ichev, J. L. Perry, and J. D. Simon, J. Phys. Chem. B, 106, 460–465 (2002).CrossRefGoogle Scholar
  22. 22.
    A. Bertuzzi, G. Mingrone, A. Gandolfi, A. V. Greco, S. Ringoir, and R. Vanholder, Clin. Chim. Acta, 265, 183–192 (1997).CrossRefGoogle Scholar
  23. 23.
    H. Athar, N. Ahmad, S. Tayyab, and M. A. Qasim, Int. J. Biol. Macromol., 25, 353–358 (1999).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2008

Authors and Affiliations

  • K. I. Mikhailopulo
    • 1
  • T. S. Serchenya
    • 1
  • E. P. Kiseleva
    • 1
  • Yu. G. Chernov
    • 1
  • T. M. Tsvetkova
    • 1
  • N. V. Kovganko
    • 1
  • O. V. Sviridov
    • 1
  1. 1.Institute of Bioorganic ChemistryNational Academy of Sciences of BelarusMinskBelarus

Personalised recommendations